淋巴细胞性白血病相关序列1抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 淋巴细胞性白血病相关序列1抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The Lyl1 gene encodes a basic helix–loop–helix transcription factor involved in T-cell acute lymphoblastic leukemia. The expression of Lyl1 is at higher levels in the majority of cases of acute myeloblastic leukemia (AML) or myelodysplastic syndrome when compared to normal bone marrow. Lyl1 is highly expressed in most AML cell lines.Lyl-1, TAL1 and TAL2 are part of a family of basic helix-loop-helix (bHLH) proteins implicated in T 淋巴细胞性白血病相关序列1抗体cell acute leukemia. TAL1, also designated SCL, is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. TAL2 is a protein involved in T cell acute lymphoblastic leukemia through a chromosomal translocation involving TAL2 and T cell receptor ∫ chain genes. TAL2 includes a helix-loop-helix protein dimerization and DNA-binding domain that is homologous to TAL1 and Lyl-1 proto-oncogenes. Lyl-1淋巴细胞性白血病相关序列1抗体 (lymphoblastic leukemia-derived sequence 1) is a nuclear protein. Endogenous Lyl-1 exists in complex with E2? proteins. Lyl-1 and E2? protein can form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Lyl-1 is involved in a chromosomal aberration which causes a form of T cell acute lymphoblastic leukemia (T-ALL).

淋巴细胞性白血病相关序列1抗体Also known as:

Lyl1; Lymphoblastic leukemia derived sequence 1; Protein lyl 1.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Pig, Cow, .

●

Immunogen: KLH conjugated synthetic peptide derived from human LYL1.

●

淋巴细胞性白血病相关序列1抗体Predicted Molecular Weight: 31kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl079Si01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)

kl081Ga01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Hu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Mu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Ra01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Si01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl083Hu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Mu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Po01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Ra01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl085Bo01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Ca01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Cp01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Hu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Mu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Po01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Ra01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl086Bo01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)

kl086Hu01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)

kl086Mu01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)

kl086Ra01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)